Melissa Angelini
Investor Relations Kontakt bei PROCAPS GROUP S.A.
Profil
Melissa Angelini is currently the Director-Investor Relations at Procaps Group SA since 2022.
Prior to this, she worked as the Head-Investor Relations at Blau Farmacêutica SA and as the Manager-Investor Relations at Biotoscana Investments SA from 2017 to 2019.
Ms. Angelini completed her undergraduate degree at Universidad de Palermo and her MBA at Insper Institute of Education & Research.
Aktive Positionen von Melissa Angelini
| Unternehmen | Position | Beginn |
|---|---|---|
| PROCAPS GROUP S.A. | Investor Relations Kontakt | 01.02.2022 |
Ehemalige bekannte Positionen von Melissa Angelini
| Unternehmen | Position | Ende |
|---|---|---|
| BLAU FARMACÊUTICA S.A. | Public Communications Contact | - |
| BIOTOSCANA INVESTMENTS S.A. | Investor Relations Kontakt | - |
Ausbildung von Melissa Angelini
| Universidad de Palermo | Undergraduate Degree |
| Insper Institute of Education & Research | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLAU FARMACÊUTICA S.A. | Health Technology |
| PROCAPS GROUP S.A. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biotoscana Investments SA
 Biotoscana Investments SA Pharmaceuticals: MajorHealth Technology Biotoscana Investments SA operates as a holding company, which engages in the development, manufacturing and commercialization of advanced medicine. Its operations include oncology, onco-hematology, severe infectious diseases, genetic and rare conditions as well as immunology and inflammation. The company was founded in August 16, 2011 and is headquartered in Montevideo, Uruguay. | Health Technology |
